Abstract
Age-related erectile dysfunction (ED) can form during ontogenesis in accordance with various mechanisms of the pathogenesis of aging in conjunction with a particular cluster of diseases. The goal of this work is to study the ontogenetic features of ED patients in late ontogeny who vary by types of aging. The study comprised 65 men over 45 years old with an explicit form of ED. The first group consisted of patients with general somatic diseases (GSDs) following the accumulative model of aging, and the second group included patients with age-associated diseases (AADs) that arose primarily from the ontogenetic model of aging. Both types of age-related ED are closely connected with ontogenetic events, especially with the onset of obesity and the loss of morning erections (which precede the onset of ED), on average over a decade of life. ED with AADs is the most clinically and pathogenetically compromised. Thus, it is characterized by an earlier age of ED onset, a dysmetabolic pattern, a low geroprotective pattern, a poor quality of primary health, pronounced instability of the gonadostat, a weak sexual constitution, decreased sensitivity of the hypothalamic-pituitary complex to feedback signals, and a large proliferative pattern. ED associated with GSDs had a later age of ED onset, developed much later from the onset of obesity, and had a lower level of testicular volume with a more conserved incretory function but a higher index of IPSS. Therefore, the separation of two ED variants associated with different types of aging in conjunction with the use of ontogenetic analysis allowed the identification of significant differences in clinical and pathogenic forms, which is important for the development of ideas on the diagnosis and treatment of age-related ED.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Vasil’chenko, G.S., Agarkova, T.E., Agarkov, S.T., et al., Seksopatologiya: Spravochnik (Sexopathology: Handbook), Moscow: Meditsina, 1990.
Dedov, I.I., Mel’nichenko, G.A., Rozhivanov, R.V., and Kurbatov, D.G., Recommendations for diagnostics and treatment of testosterone deficiency (hypogonadism) in men, Probl. Endokrinol., 2015, vol. 61, no. 5, pp. 60–71.
Russian Society of Cardiology: National Guidelines on Metabolic Syndrome, Kardiovask. Ter. Profil., 2007, vol. 6, suppl. 6, pp. 1–26.
Dil’man, V.M., Chetyre modeli meditsiny (Four Models of Medicine), Leningrad: Meditsina, 1987.
Kad’yan, A.A., Naselenie Sankt-Peterburgskikh gradskikh bogadelen (materially k izucheniyu starosti po issledovaniyu, proizvedennomu pod rukovodstvom S.P. Botkina v 1889 g.) (Population of St. Petersburg City Almshouses: The Data for Study Elderly according to the Research of S.P. Botkin in 1889), St. Petersburg, 1890.
Odin, V.I., Gamayunova, V.B., and Bershtein, L.M., Content of dehydroepiandrosterone, testosterone and cortisol in newly diagnosed type 2 diabetes, Probl. Endokrinol., 1999, vol. 45, no. 5, pp. 18–21.
Odin, V.I., Gerontology crisis: question on primary health in the 20th century, Adv. Gerontol., 2011, vol. 1, no. 4, pp. 273–283.
Odin, V.I., Didenko, V.I., Kochanova, E.A., et al., Types of aging and vegetative status of patients with erectile dysfunction in late ontogenesis, Vestn. Ross. Voen.-Med. Akad., 2017, vol. 3, no. 59, pp. 105–108.
Odin, V.I., Dvorovkin, A.E., Inamova, O.V., et al., Ontogenetic forms of rheumatoid arthritis associated with autoimmune thyroiditis, Usp. Gerontol., 2018, vol. 31, no. 1, pp. 126–131.
Brand, J.S., van der Tweel, I., Grobbee, D.E., et al., Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies, Int. J. Epidemiol., 2011, vol. 40, no. 1, pp. 189–207.
Corona, G., Vignozzi, L., Sforza, A., et al., Obesity and late-onset hypogonadism, Mol. Cell. Endocrinol., 2015, vol. 418, pp. 120–133.
Dilman, V.M., Development, Aging, and Disease. A New Rationale for and Intervention Strategy, Chur: Harwood Academic, 1994.
Handelsman, D.J. and Staraj, S., Testicular size: the effects of aging, malnutrition, and illness, J. Androl., 1985, vol. 6, no. 3, pp. 144–151.
Heinemann, L.A.J., et al., The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions, Health Qual. Life Outcomes, 2003, vol. 1, pp. 15–21.
Jockenhovet, F., Male Hypogonadism, Bremen: Uni-Med, 2004.
Korenchevsky, V.G., Physiological and Pathological Ageing, Basel: S. Karger Verlag, 1961.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence, JAMA, J. Am. Med. Assoc., 1993, vol. 270, no. 1, pp. 83–90.
Quilter, M., Hodges, L., von Hurst, P., et al., Male sexual function in New Zealand: a population-based cross-sectional survey of the prevalence of erectile dysfunction in men aged 40–70 years, J. Sex. Med., 2017, vol. 14, no. 7, pp. 928–936.
Rosen, R.C., Riley, A., Wagner, G., et al., The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 1997, vol. 49, no. 6, pp. 822–830.
Tewari, R., Rajender, S., Natu, S.M., et al., Diet, obesity, and prostate health: are we missing the link?, J. Androl., 2012, vol. 33, no. 5, pp. 763–776.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated by E. Sherstyuk
Rights and permissions
About this article
Cite this article
Odin, V.I., Didenko, V.I. Ontogenetic Characteristics of Patients with Erectile Dysfunction with Different Types of Aging. Adv Gerontol 9, 86–90 (2019). https://doi.org/10.1134/S2079057019010119
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079057019010119